Biotech · Private company · Waltham, MA, US
Affinia Therapeutics Inc.
SEC CIK 0001792694
Track this companyFree. Adds Affinia Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- AFTX-201Phase 2 · Dilated Cardiomyopathy (DCM)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)PHASE1_PHASE2 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07426419 · fetched Nov 12, 2026